Select Page

Aurinia Pharmaceuticals Class Action Lawsuit AUPH | Deadline June 14, 2022

Aurinia Pharmaceuticals Class Action Lawsuit
(AUPH Lawsuit)

The Gross Law Firm notifies investors that a class action (Aurinia Pharmaceuticals Class Action Lawsuit) has commenced in the United States District Court for the Eastern District of New York on behalf of shareholders of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) who purchased shares between May 7, 2021 and February 25, 2022.

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that:

(i) Aurinia was experiencing declining revenues; (ii) Aurinia’s 2022 sales outlook for the Company’s only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS’s commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.

Shareholders have until June 14, 2022 to request that the court appoint them lead plaintiff.

To receive more information, please fill out the form.

Aurinia Pharmaceuticals, Inc. Class Action Lawsuit
Aurinia Pharmaceuticals, Inc. Lawsuit
AUPH Class Action Lawsuit
AUPH Lawsuit
Aurinia Pharmaceuticals, Inc. (AUPH) Class Action Lawsuit
AUPH Lawsuit,
AUPH Stock